跳到主要內容

電解質補充 electrolyte supplement

 電解質補充 electrolyte supplement

以下內容部分來自經驗,部分來自資料庫,僅供參考

藥物

敘述

低血鈉

Normal saline

一般低血鈉用500 ml生理食鹽水即可,盡量不要用3% saline

Sodium chloride 3%

經驗3% saline 50ml and run 8ml/hr,病人血鈉從127爬升到136 mEq/L,可用0.5 ml/kg/day去補比較安全

***注意每天補不得超過6-8 mEq/L以防產生central pontine myelinolysis/osmotic demyelination syndrome

 

Uptodate

l   Asymptomatic, acute serum sodium <130 mEq/L —usually treat with a 50 mL bolus of 3 percent saline (ie, hypertonic saline) to prevent the serum sodium from falling further

l   Symptomatic (seizures, obtundation, coma, respiratory arrest, headache, nausea, vomiting, tremors, gait or movement disturbances, or confusion), acute serum sodium <130 mEq/L—100 mL bolus of 3 percent saline, followed, if symptoms persist, with up to two additional 100 mL doses (to a total dose of 300 mL); each bolus is infused over 10 minutes.

l   Severe symptoms or known intracranial pathology — In all patients with severe symptoms of hyponatremia (eg, seizures, obtundation, coma, respiratory arrest), 100 mL bolus of 3% saline followed, if symptoms persist, by up to two additional 100 mL doses (to a total dose of 300 mL); each bolus is infused over 10 minutes .

l   Patients with severe chronic hyponatremia (serum sodium <120 mEq/L) —initiate intravenous 3% saline beginning at a rate of 15 to 30 mL/hour, administered via a peripheral vein; we use 3 percent saline (rather than normal saline) in patients with and without suspected hypovolemia.

低血鉀

K-supply tab, potassium gluconate, 2.54 mEq

可以3# TID使用,藥物很大顆。

K-Glu oral solution, potassium gluconate, 20 mEq

可以1# TID使用,不是很好喝。

KCl 20 mEq in 500 ml normal saline

個人經驗用在血鉀 < 3 mEq/L

<2.5 mEq/L的時候可以BID2-3

< 3 mEq/L>2.5 mEq/LQD補充3

KCl 20mEq in 100 ml normal saline

濃度高,從central line給予。

低血鈣

Vitacal, 2% calcium chloride in 20ml 10% glucose solution

total 400 mg calcium chloride

total 108 mg elemental calcium

一支可以補大概0.5 mg/dlcorrected serum calcium

用於corrected serum calcium <= 7.5 mg/dl free calcium <= 0.8 mmol/L

Calcium carbonate tab 500 mg

total 200 mg elemental calcium

1# BID-QID, 也可2# QD-BID

Bio-cal plus chewable tab [Tricalcium phosphate 1203 mg + cholecalciferol (D3) 330 IU]

total 450 mg elemental calcium

2-3# QD

All-right calcium suspension

Ca3(PO4)2 + vitamin A + vitamin D3

40 mg elemental calcium + 40 mcg vitamin A + 4 mcg vitamin D4 / ml

10-15 ml/day

Uptodate

l   Asymptomatic, corrected serum calcium > 7.5 mg/dl free calcium > 0.8 mmol/L:口服

l   Asymptomatic, corrected serum calcium <= 7.5 mg/dl free calcium <= 0.8 mmol/L90-180 mg elemental calcium over 10 to 20 minutes,約等於1# vitalcal

l   Acute, symptomatic:補200-1,000 mg calcium chloride QD

l   Severe, symptomatic (eg, seizure, tetany):補充1,000 mg calcium chloride over 10 minutes; repeat every 60 minutes until symptoms resolve

l   補鉀的時候,若要同時補bicarbonate或磷,需要從另一條管路給予

低血磷

酵母粉yeast powder

Phosphate 1477 mg (15.6 mmol)/100 g

2 spoon TID

參考病人吃三天,血磷從1.3爬到2

Neutral phosphate

4.5 g elemental phosphate (47 mmol)

1.2-1.5 g daily

但可以吃到 3 g daily以上

*** 65 kg F 血磷 0.9 mg/dl,補 1 g TID,隔天4.7 mg/dl

(此病人有lung adenocarcinoma w/ bone mets c/w hypocalcemia及central DI)

Potassium phosphate 20 ml

1860 mg (60 mmol) elemental phosphate

88 mEq elemental potassium

使用時要密切監控,建議在加護病房使用,使用時從中心靜脈導管給予,0.5 #500 ml normal saline跑兩小時

***經驗則是0.25# in 250 ml NS, run 12 hr

Uptodate

l   Asymptomatic patients with a serum phosphate < 2.0 mg/dL (0.64 mmol/L):口服補充,因症狀及肌肉病變在此時可能不明顯

l   Symptomatic patients with a serum phosphate between 1.0 to 1.9 mg/dL (0.32 to 0.63 mmol/L):口服補充

l   Symptomatic patients with a serum phosphate < 1.0 mg/dL (0.32 mmol/L):點滴補充,當補到1.5 mg/dL時改成口服

l   治療劑量給予方式

n   serum phosphate >= 1.5 mg/dL (0.48 mmol/L)1 mmol/kg of elemental phosphorus (minimum of 40 mmol and a maximum of 80 mmol)一天內分成三四次給予(腎臟功能不佳需減半)

n   serum phosphate < 1.5 mg/dL (0.48 mmol/L)1.3 mmol/kg of elemental phosphorus (a maximum of 100 mmol)一天內分成三四次給予(腎臟功能不佳需減半)

n   serum phosphate >= 1.25 mg/dL (0.40 mmol/L)0.08-0.24 mmol/kg over 6 hours (up to a maximum total dose of 30 mmol)

n   serum phosphate < 1.25 mg/dL (0.40 mmol/L)0.25-0.50 mmol/kg over 8 to 12 hours (up to a maximum total dose of 80 mmol)

低血鎂

Magnesium oxide 250 mg

Asymptomatic1# TID-QID

(5-10 mg/kg)

Magnesium sulfate 10% 20 ml

16.24 mEq/amp

Uptodate

l   Non severe32 to 64 mEq (16 to 32 mmol) IVD over 24 hours

l   hemodynamically stable patients with severe symptomatic hypomagnesemia (<= 1 mg/dL [0.4 mmol/L or 0.8 mEq/L])8-16 mEq (4-8 mmol) in 50-100 D5W IVD in 5-60 minutes followed by infusion

l   Severe, hemodynamically unstable pts  (including those with arrhythmias consistent with torsade de pointes or hypomagnesemic hypokalemia): 8-16 mEq (4-8 mmol) IVD in 10-15 minutes

 

參考案例
samll bowel obstruction住院
(理由不明,沒有手術hx)
NPO超過20天以上
5/24日開始灌食(當天1000kcal, BW 50.4kg)
昨天拉了6次大便,黃軟便
今天抽血(超過一個月沒抽血)
Na: 131
K: 2.0
IP: 1.4
Mg: 1.29
free Ca: 0.89 mmol/L
Hx: HF, HTN, PAOD
r/o refeeding syndrome
 
建議處置可能如下
熱量10kcal/kg=> 500kcal給起
KCl 20mEq BID 2
vitacal 1# QD 4
mag. sulfate 1# once
yeast powder 2 spoons TID $
vitamin B1 1# BID 5
 

留言

這個網誌中的熱門文章

2021慢性正常收縮分率心衰竭的治療 Management of Chronic HFpEF of ESC Guideline in 2021

2021 慢性 正常收縮分率心衰竭 的治療   Management of Chronic Heart failure with Preserved Ejection Fraction of ESC Guideline in 2021 l    診斷: 症狀 ± 徵象、 LVEF ≥ 50% 、客觀證據顯示符合 LV 舒張異常、 LV filling pressures 上升的心臟結構或功能異常 ( 包含 NPs 上升 ) ,所謂客觀證據參考下表 參數 門檻 備註 LV mass index Relative wall thickness 女: ≥ 95 g/m 2 ;男: ≥ 115 g/m 2 > 0.42 若有出現同心 (concentric) LV remodeling 或 LVH 會支持此診斷,但沒有無法排除 HFpEF   LA volume index >34 mL/m 2 (SR) >40 mL/m 2 (AF) 在沒有 AF 和瓣膜疾病的情況下, LA enlargement 反應慢性 LV filling pressure 過高 E/e’ ratio at rest >9 利用 invasive exercise testing 診斷 HFpEF 的 sensitivity 78% 、 specificity 59% ;若設定為 >13 , sensitivity 46% 、 specificity 86% NT-proBNP BNP >125 (SR) 或 >365 (AF) pg/mL >35 (SR) 或 >105 (AF) pg/mL 在用侵入性檢查證實 HFpEF 的病人中, 高達 20% 的病人 NPs 低於診斷門檻 ,特別是肥胖的病人 PA systolic pressure TR velocity a

目錄

目錄   l    文書相關 n    病例寫作常用句子及應注意文句 l    臨床操作 n    子宮頸抹片 pap smears 及內診 per vaginal examination (OSCE 攻略 ) n    乳房腫塊 breast mass 與乳 房觸診 breast palpation (OSCE 攻略 ) n    鼻胃管置入 nasogastric tube insertion (OSCE 攻略 ) n    肛門指診 digital rectal examination (OSCE 攻略 ) n    靜脈留置針置入術 intravenous catheter insertion (OSCE 攻略 ) n    經口氣管插管 endotracheal Intubation (OSCE 攻略 ) n    拔除 JP 引流管 removal of Jackson-Pratt drain n    換氣切管 change tracheostomy inner tube n    如何移除硬脊膜外自控式止痛 How to remove patient-controlled epidural analgesia n    人工血管不順該怎麼處理 n    動脈導管置放 arterial line placement l    感染科 n    痰液培養 sputum culture n    抗生素的劑量調整 n    無症狀菌尿症之處置 (2019 年更新之 IDSA 臨床指引 ) Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the IDSA l    心臟內科 n    重症病人新發心房纖維性顫動之處理 management of new-onset atrial fibrillation during critical illness n    心肌梗塞之診斷 diagnosis of acute myocardial infarction n    HEART 風險評分 n    TIMI

咳血之檢查及處置survey and management of hemoptysis

  咳血之檢查及處置    survey and management of hemoptysis l    病因 呼吸道 支氣管炎 支氣管擴張 癌症 肺血管廔管 異物 支氣管結石 肺實質 肺膿瘍 肺結核 細菌感染 鉤端螺旋體病 Leptospirosis 寄生蟲 ( 例如 Paragonimus westermani, Strongyloides) 病毒感染 Goodpasture disease Behçet disease 血管炎 紅斑性狼瘡 (SLE) 子宮內膜異位症   心血管疾病 心臟衰竭 二尖瓣狹窄 肺栓塞 Pulmonary artery pseudoaneurysm 肺部動靜脈畸型 Pulmonary arteriovenous malformation Pulmonary and bronchial artery aneurysms 肺靜脈閉塞病 Pulmonary veno-occlusive disease     出血問題或創傷 服用抗凝血劑 泛發性血管內血液凝固症 (DIC) 血小板功能障礙 血小板低下 Von Willebrand disease   挫傷或穿刺傷 呼吸道支架 氣管氣球擴張術 切片 氣管插管侵